🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalHas anyone dealt with german private insurance (pkv) vs statutory (gkv)? Page 5

Has anyone dealt with german private insurance (pkv) vs statutory (gkv)?

B12Beth Sun, Jan 19, 2025 at 1:17 AM 36 replies 1,942 viewsPage 5 of 8
TomTeleRx
Member
189
678
Feb 2025
Delaware
Jan 19, 2025 at 8:22 AM#21

COA_Karl — that is really helpful context on Has anyone dealt with. Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.

17 13pete_manc_UK, anna.melb_AU, mark_tokyo and 14 others
Reply Quote Save Share Report
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Jan 19, 2025 at 8:39 AM#22

To answer DebRD_ATL's question specifically:

From a clinical standpoint, Has anyone dealt with german is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

Last edited: Jan 19, 2025 at 11:39 AM
38 12COA_Karl, MikeFit_NJ, InsuranceTom and 35 others
Reply Quote Save Share Report
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Jan 19, 2025 at 8:56 AM#23

Thank you TomTeleRx! This is incredibly helpful. Bookmarking for later. 🙏

16 8Dr.ReproEndo, lucas_SP_BR, lisa_labSD and 13 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Jan 19, 2025 at 9:13 AM#24

Relevant to Has anyone dealt with german — here is my latest bloodwork comparison:

Key improvements: A1C 7.6% → 5.5%, triglycerides 241 → 111 mg/dL, hsCRP 8.0 → 1.1 mg/L. All on tirzepatide for 9 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

Last edited: Jan 19, 2025 at 10:13 AM
26 17DebRD_ATL, KristenIndy, MarkLI_maint and 23 others
Reply Quote Save Share Report
anna.melb_AU
Member
678
2,890
Apr 2024
Melbourne, AU
Jan 19, 2025 at 9:30 AM#25

Slightly tangential to Has anyone dealt with but TomTeleRx reminded me — what is the latest on the oral formulations?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: Jan 19, 2025 at 1:30 PM
30 19Dr.LipidDallas, alex_tucson, kevin_tulsa and 27 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register